A retrospective observational study also found that DPP4-i attenuates the decline of skeletal muscle mass in patients with type 2 diabetes.[93] DPP4 has potential as a potential treatment for sarcopenia. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.